Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 10.8B | 7.0B | 11.9B | 9.3B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 1.1B | 716.1M | 1.3B | 587M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 4.5B | 4.2B | -36.8B | 4.4B |
| Tax provision | 1.3B | 1.1B | -9.2B | 1.1B |
| Net income | 3.2B | 3.0B | -27.6B | 3.3B |
| Basic EPS | — | 4.2 | -44.2 | 5.4 |
| Diluted EPS | — | 4.2 | -44.2 | 5.4 |
| Basic average shares | — | 725.3M | 624.2M | 601.8M |
| Diluted average shares | — | 727.0M | 624.2M | 604.0M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |